0.32
-5.88%
Close of 9 Nov 2026, in HKD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Qianhai Health Holdings
Its shares trade on HKEX under the ticker 911.HK. It has been listed since 27 June 2014. In the fiscal year to 31 December 2024, it reported net income of HK$1.3m. At that date it held total assets of HK$407.3m and shareholders' equity of HK$385.6m.
Qianhai Health Holdings Ltd. engages in the sourcing and wholesaling of unprocessed American ginseng. The company employs 15 full-time employees The company went IPO on 2014-06-27. Along with subsidiaries, the Company operates its business through four segments. The Cultivated Ginseng segment is engaged in the purchasing and sale of cultivated American ginseng. The Wild Ginseng segment is engaged in the purchasing and sale of wild ginseng from the United States. The Ginseng Wine segment is engaged in the manufacturing and sale of ginseng wine. Its wine products include American wild ginseng brandy and American wild ginseng white spirit. The Others segment is engaged in the trading of other products, including dried cordyceps, dried cubilose, dried seafood and skin care products, among others.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Consumer Discretionary
- Industry
- Distributors
- Listed since
- 27 Jun 2014
- Employees
- 15
- Website
- qianhaihealth.com.hk ↗
Leadership
Pay as last reported
- Mr. Zhiqun HuangNon-Executive Chairman of the Board
- Ms. Tak Yung YipChief Financial Officer, Company Secretary
- Mr. Wing Kong YeungGeneral Manager, since 2011HK$2.7m
- Mr. Yu Yuan TangExecutive Director
- Mr. Chee Lap YuenExecutive Director, since 2016HK$180,000
- Mr. Kai Ben ChenNon-Executive Director
- Mr. Qi ChenNon-Executive Director
- Mr. Chun Tung LeungNon-Executive Independent Director
- Mr. Weikang LiIndependent Non-Executive DirectorHK$180,000
- Ms. Hung Yu WuNon-Executive Independent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Qianhai Health Holdings Ltd. sources unprocessed American ginseng directly from the United States.
- The company operates four business segments including cultivated and wild ginseng sales.
- Qianhai Health Holdings Ltd. manufactures and sells ginseng wine products like brandy and white spirit.
Weaknesses
- The company employs only 15 full-time employees, limiting operational capacity.
- Qianhai Health Holdings Ltd. has no subsidiaries mentioned in the business description.
- The company's IPO was in 2014, indicating limited recent market activity.
Opportunities
- Expanding the Ginseng Wine segment could increase revenue from premium products.
- The Wild Ginseng segment can leverage U.S. sourcing for higher demand.
- The Others segment offers potential for growth in dried cordyceps and skincare products.
Threats
- Dependence on U.S. ginseng sources may lead to supply chain disruptions.
- The small employee count of 15 may hinder scalability during market changes.
- Limited market presence in the Consumer Discretionary sector could affect growth.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.